MeSH term
Frequency | Condition_Probility | ATP-Binding Cassette Transporters/metabolism | 7 | 14.0 |
Antigen Presentation | 11 | 3.0 |
Antiporters/metabolism | 3 | 50.0 |
Cysteine Endopeptidases/metabolism | 5 | 2.0 |
Down-Regulation | 12 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Histocompatibility Antigens Class I/genetics/*metabolism | 4 | 13.0 |
Humans | 250 | 0.0 |
Immunoglobulins/metabolism | 4 | 3.0 |
*Major Histocompatibility Complex | 17 | 5.0 |
Multienzyme Complexes/metabolism | 3 | 1.0 |
Mutation | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 192 | 0.0 |
Animals | 90 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Blotting, Western | 6 | 0.0 |
Cells, Cultured | 11 | 0.0 |
Comparative Study | 30 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Interferon Type II/pharmacology | 4 | 0.0 |
Interferon-beta/pharmacology | 2 | 4.0 |
Mice | 55 | 0.0 |
Mice, Inbred C57BL | 19 | 0.0 |
Molecular Sequence Data | 84 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Time Factors | 5 | 0.0 |
ATP-Binding Cassette Transporters/*metabolism | 9 | 11.0 |
Adenosine Triphosphate/metabolism | 8 | 1.0 |
Cell Line | 45 | 0.0 |
HLA-A2 Antigen/metabolism | 2 | 12.0 |
HLA-B Antigens/metabolism | 2 | 20.0 |
Macromolecular Substances | 8 | 0.0 |
Rats | 24 | 0.0 |
Transfection | 26 | 0.0 |
ATP-Binding Cassette Transporters/*genetics | 64 | 27.0 |
Female | 69 | 0.0 |
Genetic Predisposition to Disease | 14 | 0.0 |
Male | 56 | 0.0 |
Middle Aged | 24 | 0.0 |
*Polymorphism, Genetic | 33 | 0.0 |
3T3 Cells | 2 | 0.0 |
ATP-Binding Cassette Transporters/biosynthesis/genetics/*immunology | 2 | 100.0 |
Cell Line, Transformed | 5 | 0.0 |
Interferon Type II/biosynthesis/immunology | 2 | 12.0 |
Mice, Inbred BALB C | 6 | 0.0 |
T-Lymphocytes/immunology | 3 | 0.0 |
Adolescent | 22 | 0.0 |
Adult | 35 | 0.0 |
Alleles | 57 | 0.0 |
DNA Primers/genetics | 4 | 0.0 |
Electrophoresis, Agar Gel | 2 | 0.0 |
Epidemiology, Molecular | 2 | 2.0 |
Genotype | 28 | 0.0 |
Heterozygote | 5 | 0.0 |
Homozygote | 4 | 0.0 |
Japan | 8 | 0.0 |
Major Histocompatibility Complex | 13 | 5.0 |
Polymerase Chain Reaction | 28 | 0.0 |
Rhinitis, Allergic, Perennial/epidemiology/*genetics | 2 | 100.0 |
Child | 18 | 0.0 |
Child, Preschool | 10 | 0.0 |
Protein Biosynthesis | 9 | 0.0 |
Proteins/genetics | 9 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 76 | 0.0 |
Base Sequence | 55 | 0.0 |
Case-Control Studies | 9 | 0.0 |
Diabetes Mellitus, Type 1/*genetics | 6 | 2.0 |
Finland | 2 | 0.0 |
Gene Frequency | 32 | 0.0 |
Genes, MHC Class II | 8 | 3.0 |
Linkage Disequilibrium | 14 | 1.0 |
ATP-Binding Cassette Transporters/biosynthesis/genetics | 3 | 42.0 |
*Gene Expression Regulation, Viral | 2 | 0.0 |
*Genes, MHC Class I | 7 | 2.0 |
Histocompatibility Antigens Class I/*biosynthesis | 4 | 10.0 |
NF-kappa B/metabolism | 3 | 0.0 |
Neoplasm Proteins/biosynthesis/genetics | 3 | 2.0 |
Phosphorylation | 3 | 0.0 |
Protein Processing, Post-Translational | 4 | 0.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Tumor Cells, Cultured/immunology | 2 | 2.0 |
Gene Expression Regulation, Neoplastic | 8 | 0.0 |
Tumor Cells, Cultured | 32 | 0.0 |
COS Cells | 3 | 0.0 |
Polymorphism, Genetic/*genetics | 4 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Viral Matrix Proteins/*genetics | 2 | 12.0 |
*Genes, MHC Class II | 16 | 5.0 |
HLA-DQ Antigens/*genetics | 7 | 1.0 |
HLA-DR Antigens/*genetics | 7 | 1.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Immunoblotting | 2 | 0.0 |
Protein Binding | 18 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
China/ethnology | 3 | 1.0 |
Chromosome Mapping | 11 | 0.0 |
*Cysteine Endopeptidases | 34 | 72.0 |
HLA-D Antigens/*genetics | 9 | 6.0 |
Proteins/*genetics | 15 | 0.0 |
ATP-Binding Cassette Transporters/*physiology | 3 | 13.0 |
Immunity/physiology | 2 | 14.0 |
T-Lymphocytes, Cytotoxic/immunology | 6 | 1.0 |
HLA-B Antigens/*genetics | 2 | 0.0 |
Korea | 2 | 0.0 |
*Multienzyme Complexes | 22 | 29.0 |
Phenotype | 8 | 0.0 |
Polymorphism, Genetic | 22 | 0.0 |
ATP-Binding Cassette Transporters/genetics | 15 | 23.0 |
*Amino Acid Transport Systems | 5 | 41.0 |
Graves' Disease/*genetics | 2 | 5.0 |
HLA-DR Antigens/genetics | 21 | 5.0 |
Lymphotoxin/genetics | 3 | 5.0 |
Polymerase Chain Reaction/methods | 6 | 0.0 |
*Saccharomyces cerevisiae Proteins | 5 | 0.0 |
Tumor Necrosis Factor-alpha/genetics | 4 | 1.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Regression Analysis | 2 | 0.0 |
Risk Factors | 3 | 0.0 |
HLA Antigens/*genetics | 7 | 0.0 |
HLA-DQ Antigens/genetics | 15 | 5.0 |
Haplotypes/genetics | 2 | 0.0 |
Amino Acid Sequence | 52 | 0.0 |
Binding Sites | 13 | 0.0 |
Cloning, Molecular | 13 | 0.0 |
Models, Molecular | 3 | 0.0 |
Protein Conformation | 5 | 0.0 |
Protein Subunits | 5 | 1.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Sequence Alignment | 9 | 0.0 |
Sequence Homology, Amino Acid | 11 | 0.0 |
ATP-Binding Cassette Transporters/genetics/*metabolism | 6 | 10.0 |
Adenosine Triphosphate/*metabolism | 10 | 11.0 |
Chimeric Proteins/metabolism | 2 | 1.0 |
Flow Cytometry | 14 | 0.0 |
Nucleotides/*metabolism | 3 | 15.0 |
Protein Structure, Tertiary | 5 | 0.0 |
DNA Primers | 9 | 0.0 |
Mice, Mutant Strains | 8 | 1.0 |
Gene Library | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Viral Matrix Proteins/biosynthesis/*genetics | 2 | 100.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Gene Expression | 6 | 0.0 |
Mitoxantrone/*pharmacology | 2 | 33.0 |
Amino Acid Motifs | 3 | 0.0 |
Dimerization | 9 | 0.0 |
Hydrolysis | 3 | 0.0 |
Adenosine Diphosphate/metabolism | 3 | 5.0 |
Microsomes/metabolism | 4 | 3.0 |
Protein Transport | 4 | 0.0 |
Spodoptera | 3 | 1.0 |
ATP-Binding Cassette Transporters/chemistry/*metabolism | 3 | 30.0 |
Hela Cells | 7 | 0.0 |
Mutagenesis, Site-Directed | 7 | 0.0 |
English Abstract | 4 | 0.0 |
ATP-Binding Cassette Transporters/*analysis | 5 | 83.0 |
Histocompatibility Antigens Class I/*analysis | 2 | 4.0 |
Immunohistochemistry | 10 | 0.0 |
Down-Regulation/genetics/*immunology | 2 | 10.0 |
HLA Antigens/*biosynthesis | 2 | 10.0 |
Histocompatibility Antigens Class I/biosynthesis | 4 | 8.0 |
*Viral Proteins | 4 | 2.0 |
ATP-Binding Cassette Transporters/genetics/metabolism/*physiology | 2 | 25.0 |
Biological Transport | 24 | 1.0 |
Peptides/metabolism | 4 | 1.0 |
African Continental Ancestry Group/*genetics | 3 | 1.0 |
*Alleles | 10 | 0.0 |
Haplotypes | 17 | 0.0 |
Pan troglodytes | 2 | 1.0 |
Variation (Genetics) | 5 | 0.0 |
ATP-Binding Cassette Transporters/classification/*genetics | 2 | 50.0 |
*Polymorphism, Single-Stranded Conformational | 3 | 2.0 |
ATP-Binding Cassette Transporters/biosynthesis | 2 | 18.0 |
Aged | 11 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Disease Progression | 2 | 0.0 |
*Down-Regulation | 4 | 1.0 |
Neoplasm Metastasis | 2 | 0.0 |
Recurrence | 2 | 0.0 |
beta 2-Microglobulin/biosynthesis | 2 | 16.0 |
Antigen Presentation/*genetics | 8 | 44.0 |
Genes, MHC Class I | 7 | 5.0 |
Gorilla gorilla | 2 | 5.0 |
Hamsters | 4 | 0.0 |
Sequence Analysis, DNA | 5 | 0.0 |
Polymorphism, Single-Stranded Conformational | 5 | 0.0 |
ATP-Binding Cassette Transporters/genetics/immunology | 2 | 66.0 |
HLA Antigens/*biosynthesis/genetics/immunology | 2 | 100.0 |
Blotting, Southern | 2 | 0.0 |
HLA-DP Antigens/genetics | 5 | 10.0 |
Models, Genetic | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
ATP-Binding Cassette Transporters/*genetics/immunology | 8 | 80.0 |
Crosses, Genetic | 3 | 0.0 |
Gene Deletion | 4 | 0.0 |
Immunity, Cellular/genetics | 2 | 18.0 |
Mice, Knockout | 6 | 0.0 |
T-Lymphocytes/*immunology | 4 | 0.0 |
*Proteasome Endopeptidase Complex | 2 | 3.0 |
Affinity Labels | 3 | 5.0 |
Histocompatibility Antigens Class I/metabolism | 7 | 10.0 |
In Vitro | 3 | 0.0 |
*Antigen Presentation/genetics | 3 | 20.0 |
Cytotoxicity Tests, Immunologic | 2 | 0.0 |
Genetic Vectors/chemical synthesis | 2 | 16.0 |
Histocompatibility Antigens Class I/biosynthesis/genetics | 2 | 28.0 |
Sequence Deletion | 4 | 0.0 |
Antigens, CD/metabolism | 2 | 0.0 |
Antiporters/*metabolism | 2 | 25.0 |
Histocompatibility Antigens Class I/*metabolism | 16 | 16.0 |
Immunoglobulins/*metabolism | 2 | 3.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Substrate Specificity | 5 | 0.0 |
ATP-Binding Cassette Transporters/*chemistry/genetics | 2 | 50.0 |
Insects | 3 | 1.0 |
Kinetics | 3 | 0.0 |
*Mutation | 3 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Temperature | 4 | 0.0 |
Disease Susceptibility | 12 | 1.0 |
Major Histocompatibility Complex/*genetics | 11 | 7.0 |
Odds Ratio | 3 | 0.0 |
Spondylitis, Ankylosing/*genetics | 2 | 7.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Pregnancy | 5 | 0.0 |
ATP-Binding Cassette Transporters/biosynthesis/*genetics | 3 | 27.0 |
Promoter Regions (Genetics) | 7 | 0.0 |
ATP-Binding Cassette Transporters/genetics/*immunology | 2 | 100.0 |
Drosophila melanogaster | 2 | 1.0 |
H-2 Antigens/genetics/immunology | 2 | 20.0 |
Mice, Inbred C3H | 2 | 0.0 |
Mice, Transgenic | 5 | 0.0 |
T-Lymphocytes, Cytotoxic/*immunology | 3 | 0.0 |
ATP-Binding Cassette Transporters/genetics/metabolism | 3 | 11.0 |
Immunity, Cellular | 3 | 0.0 |
*Genetic Predisposition to Disease | 9 | 0.0 |
Microsatellite Repeats | 5 | 0.0 |
Sarcoidosis/*genetics | 2 | 12.0 |
Antigen Presentation/*genetics/immunology | 3 | 100.0 |
Graft Rejection/*genetics/immunology | 2 | 22.0 |
*Histocompatibility Antigens Class II | 6 | 9.0 |
Kidney Transplantation/*immunology | 3 | 1.0 |
Drug Resistance, Neoplasm/drug effects/genetics/*physiology | 2 | 100.0 |
Electrophoresis, Gel, Two-Dimensional/methods | 2 | 9.0 |
Heat | 2 | 0.0 |
Neoplasm Proteins/analysis/genetics/*metabolism | 2 | 33.0 |
Neoplasms/drug therapy/genetics/*metabolism | 2 | 50.0 |
*Proteomics | 2 | 4.0 |
Tumor Markers, Biological/metabolism | 2 | 0.0 |
*Antigen Presentation | 17 | 10.0 |
Transcription, Genetic | 4 | 0.0 |
Up-Regulation | 5 | 0.0 |
Carrier Proteins/*metabolism | 5 | 0.0 |
HLA-A2 Antigen/*genetics | 2 | 11.0 |
Proteins/metabolism | 3 | 0.0 |
beta 2-Microglobulin/*metabolism | 2 | 4.0 |
ATP-Binding Cassette Transporters/chemistry/genetics/*metabolism | 2 | 22.0 |
Peptide Fragments/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Antigen Presentation/genetics | 7 | 30.0 |
Antigens, Neoplasm/*immunology | 2 | 1.0 |
Cytotoxicity, Immunologic | 4 | 0.0 |
Peptides/immunology | 3 | 2.0 |
ATP-Binding Cassette Transporters/*chemistry | 3 | 100.0 |
Intracellular Membranes/metabolism | 3 | 1.0 |
Photochemistry | 3 | 5.0 |
Structure-Activity Relationship | 6 | 0.0 |
European Continental Ancestry Group/*genetics | 2 | 0.0 |
*Variation (Genetics) | 2 | 0.0 |
Viral Matrix Proteins/genetics | 2 | 9.0 |
Antigens/metabolism | 2 | 3.0 |
Endoplasmic Reticulum/immunology/metabolism | 3 | 60.0 |
Peptides/*metabolism | 3 | 1.0 |
Polymerase Chain Reaction/*methods | 2 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Mice, Inbred Strains | 5 | 0.0 |
Burkitt Lymphoma/*immunology | 2 | 10.0 |
Cysteine Endopeptidases/genetics | 3 | 25.0 |
Gene Expression Regulation, Viral | 2 | 0.0 |
Histocompatibility Antigens Class I/genetics | 4 | 4.0 |
Killer Cells, Natural/*immunology | 3 | 0.0 |
Proteasome Endopeptidase Complex | 8 | 1.0 |
*Linkage Disequilibrium | 3 | 1.0 |
Pedigree | 5 | 0.0 |
Protein p53/genetics/metabolism | 2 | 2.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
Asian Continental Ancestry Group | 2 | 0.0 |
Diabetes Mellitus, Type 1/*genetics/immunology | 6 | 10.0 |
*Microsatellite Repeats | 2 | 0.0 |
*Chromosomes, Human, Pair 6 | 3 | 1.0 |
Lymphatic Metastasis | 2 | 0.0 |
beta 2-Microglobulin/genetics | 2 | 9.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Species Specificity | 7 | 0.0 |
ATP-Binding Cassette Transporters/*genetics/metabolism | 7 | 23.0 |
ATP-Binding Cassette Transporters/*genetics/*immunology | 4 | 100.0 |
Chi-Square Distribution | 2 | 0.0 |
HLA-DP Antigens/*genetics | 2 | 2.0 |
Polymorphism, Genetic/*immunology | 4 | 12.0 |
*Polymorphism, Restriction Fragment Length | 2 | 0.0 |
ATP-Binding Cassette Transporters/*immunology | 3 | 75.0 |
CD8-Positive T-Lymphocytes/*immunology | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Cohort Studies | 2 | 0.0 |
Genes, MHC Class II/*genetics | 8 | 11.0 |
Severity of Illness Index | 3 | 0.0 |
Antigen Presentation/*immunology | 4 | 4.0 |
Calcium-Binding Proteins/metabolism | 3 | 3.0 |
Calreticulin | 2 | 8.0 |
Glycosylation | 4 | 0.0 |
Protein Binding/immunology | 2 | 1.0 |
Ribonucleoproteins/metabolism | 2 | 6.0 |
Epitopes/immunology | 2 | 0.0 |
Histocompatibility Antigens Class I/*genetics/immunology | 2 | 7.0 |
Histocompatibility Antigens Class I/*immunology | 4 | 3.0 |
Biological Transport/immunology | 3 | 11.0 |
Protein Processing, Post-Translational/immunology | 2 | 16.0 |
Interferon Type II/*pharmacology | 4 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Histocompatibility Testing | 2 | 0.0 |
ATP-Binding Cassette Transporters/*biosynthesis | 2 | 33.0 |
*Antiporters | 2 | 8.0 |
Carrier Proteins/*genetics | 18 | 1.0 |
*Immunoglobulins | 2 | 7.0 |
Consensus Sequence | 2 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
Interferon Type II/*physiology | 2 | 3.0 |
Phosphoproteins/*physiology | 2 | 2.0 |
Genes, MHC Class I/*genetics | 3 | 4.0 |
Restriction Mapping | 3 | 0.0 |
Major Histocompatibility Complex/immunology | 2 | 4.0 |
*Linkage (Genetics) | 2 | 0.0 |
beta 2-Microglobulin/metabolism | 3 | 3.0 |
Exons | 3 | 0.0 |
Introns | 3 | 0.0 |
Phylogeny | 3 | 0.0 |
Antibody Specificity | 2 | 0.0 |
HLA Antigens/metabolism | 3 | 9.0 |
*ATP-Binding Cassette Transporters | 31 | 26.0 |
Antigens, Neoplasm/*metabolism | 2 | 2.0 |
Cell Membrane/metabolism | 2 | 0.0 |
T-Lymphocytes/metabolism | 3 | 1.0 |
H-2 Antigens/immunology | 2 | 9.0 |
T-Lymphocyte Subsets/*cytology/immunology | 2 | 22.0 |
Genetic Markers | 3 | 0.0 |
Autoantibodies/analysis | 2 | 1.0 |
DNA Primers/chemistry | 7 | 0.0 |
Major Histocompatibility Complex/genetics | 5 | 8.0 |
B-Lymphocytes/*metabolism | 2 | 1.0 |
Endoplasmic Reticulum/metabolism | 9 | 3.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Recombinant Proteins | 3 | 0.0 |
Histocompatibility Antigens Class I/genetics/immunology | 2 | 13.0 |
DNA/analysis | 5 | 0.0 |
Linkage (Genetics) | 5 | 0.0 |
Genes, MHC Class II/genetics | 3 | 10.0 |
Infant, Newborn | 4 | 0.0 |
Isoantigens/immunology | 2 | 2.0 |
DNA | 2 | 0.0 |
Histocompatibility Antigens Class II/*genetics | 17 | 9.0 |
Polymorphism, Restriction Fragment Length | 7 | 0.0 |
ATP-Binding Cassette Transporters/*biosynthesis/genetics | 2 | 11.0 |
Histocompatibility Antigens Class I/analysis/physiology | 2 | 66.0 |
Psoriasis/*genetics | 2 | 3.0 |
Immunophenotyping | 6 | 0.0 |
Diabetes Mellitus, Type 1/epidemiology/*genetics | 2 | 9.0 |
Mutation/*genetics | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Infant | 5 | 0.0 |
*Exoribonucleases | 2 | 66.0 |
Melanoma/*metabolism | 2 | 3.0 |
*Recombination, Genetic | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
*Promoter Regions (Genetics) | 3 | 0.0 |
Measles Vaccine/*immunology | 2 | 40.0 |
Antibodies, Monoclonal | 3 | 0.0 |
Interferon-gamma, Recombinant/*pharmacology | 2 | 1.0 |
Thymus Gland/*cytology | 2 | 3.0 |
Major Histocompatibility Complex/*immunology | 2 | 5.0 |
Polymorphism, Genetic/immunology | 2 | 8.0 |
Cell Division | 2 | 0.0 |
Epithelial Cells | 2 | 0.0 |
Genes, MHC Class II/*immunology | 3 | 15.0 |
HLA-D Antigens/genetics | 7 | 17.0 |
Linkage Disequilibrium/*immunology | 2 | 50.0 |
Epitopes/genetics | 2 | 2.0 |
Rabbits | 2 | 0.0 |
Protein Transport/*physiology | 2 | 4.0 |
Baculoviridae/genetics | 2 | 1.0 |
Peptides/chemistry/metabolism | 3 | 6.0 |
Codon | 3 | 0.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Cytotoxicity, Immunologic/genetics | 2 | 11.0 |
Histocompatibility Antigens Class II/genetics | 4 | 3.0 |
Disease Susceptibility/immunology | 2 | 2.0 |
Recombination, Genetic | 3 | 0.0 |
Antibody Formation | 2 | 0.0 |
Polymorphism, Genetic/*physiology | 2 | 2.0 |
Multiple Sclerosis/*genetics | 4 | 4.0 |
Chromosomes, Human/*genetics | 2 | 4.0 |
Histocompatibility Antigens Class I/*genetics | 5 | 1.0 |
HLA-B27 Antigen/genetics | 2 | 12.0 |
Antigen Presentation/*physiology | 2 | 18.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
H-2 Antigens/genetics | 2 | 8.0 |
ATP-Binding Cassette Transporters/genetics/*physiology | 2 | 9.0 |
beta 2-Microglobulin/genetics/*physiology | 2 | 66.0 |
Antigen-Presenting Cells/*immunology | 2 | 1.0 |
Chromatography, Affinity | 2 | 0.0 |
Histocompatibility Antigens Class II/*metabolism | 4 | 7.0 |
Carrier Proteins/genetics | 3 | 0.0 |
Carrier Proteins/genetics/*physiology | 2 | 2.0 |
Histocompatibility Antigens Class II/genetics/*physiology | 2 | 100.0 |
Celiac Disease/*genetics | 2 | 7.0 |
Biological Transport/genetics | 2 | 4.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Taiwan/epidemiology | 2 | 1.0 |
Reference Values | 2 | 0.0 |
*Haplotypes | 2 | 0.0 |
Antigens/*metabolism | 2 | 10.0 |
Cysteine Endopeptidases/*genetics | 3 | 9.0 |
Multienzyme Complexes/*genetics | 2 | 2.0 |